candesartan has been researched along with Coronary Artery Vasospasm in 1 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirai, N | 1 |
| Kawano, H | 1 |
| Yasue, H | 1 |
| Shimomura, H | 1 |
| Miyamoto, S | 1 |
| Soejima, H | 1 |
| Kajiwara, I | 1 |
| Sakamoto, T | 1 |
| Yoshimura, M | 1 |
| Nakamura, H | 1 |
| Yodoi, J | 1 |
| Ogawa, H | 1 |
1 trial available for candesartan and Coronary Artery Vasospasm
| Article | Year |
|---|---|
Attenuation of nitrate tolerance and oxidative stress by an angiotensin II receptor blocker in patients with coronary spastic angina.
Topics: Administration, Cutaneous; Aged; Angina Pectoris; Angiotensin Receptor Antagonists; Benzimidazoles; | 2003 |